One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Thursday. This fund sold over 300,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares, as the price of this ETF was down over 1% on Thursday. Note that this fund is still up handily in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Thursday’s closing price, this would have valued this sale at $7.0 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 36% in the past year.
Check out all of the ARK Invest sales for Thursday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 4477JP | BASE | 22,900 |
| ARKF | GOOG | ALPHABET | 131 |
| ARKF | 9923HK | YEAHKA | 252,800 |
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 638,800 |
| ARKG | BMY | BRISTOL-MYERS SQUIBB | 29,000 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 15,505 |
| ARKG | RHHBY | ROCHE | 32,600 |
| ARKG | MCRB | SERES THERAPEUTICS | 400 |
| ARKG | SEER | SEER | 20,000 |
| ARKK | NSTG | NANOSTRING TECHNOLOGIES | 144,340 |
| ARKK | NTDOY | NINTENDO | 38,500 |
| ARKK | SE | SEA | 71,593 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 302,190 |
| ARKQ | BABA | ALIBABA | 46,900 |
| ARKQ | XONE | EXONE | 10,000 |
| ARKW | LC | LENDINGCLUB | 32,700 |
| ARKW | OKTA | OKTA | 31,041 |
| ARKW | SQ | SQUARE | 21,732 |
| ARKX | TRMB | TRIMBLE | 9,167 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
24/7 Wall St.Credit card companies are handing out rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
